MedTrace Logo

Assessing the Effects of ELO Water on Diabetic Foot Ulcers

NCT05908968 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2023-06-18

No results posted yet for this study

Summary

This pilot study examined the effects of ELO water, a commercially-available oxygen-enriched drinking water, on wound healing in patients with diabetic foot ulcers over 12 weeks.

Conditions

  • Foot Ulcer, Diabetic

Interventions

DIETARY_SUPPLEMENT

ELO water

Drinking 1.5 litres daily of ELO water for 12 weeks

Sponsors & Collaborators

  • ELO Water Pte. Ltd.

    collaborator INDUSTRY

  • Changi General Hospital

    lead OTHER

Principal Investigators

  • Joan Khoo · Changi General Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-19
Primary Completion
2019-11-30
Completion
2021-06-30

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05908968 on ClinicalTrials.gov